581 Final analysis of 2-THE-TOP: a phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma

• David Tran,
• Ashley Ghiaseddin,
• Dongjiang Chen,
• Son Le

Affiliations

David Tran

1University of Florida, Gainesville, FL, USA

Ashley Ghiaseddin

1University of Florida, Gainesville, FL, USA

Dongjiang Chen

2University of Southern California, Los Angeles, CA, USA

Son Le

2University of Southern California, Los Angeles, CA, USA